CAS 535-75-1|Pipecolinic acid
| Common Name | Pipecolinic acid | ||
|---|---|---|---|
| CAS Number | 535-75-1 | Molecular Weight | 129.157 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 265.8±33.0 °C at 760 mmHg |
| Molecular Formula | C6H11NO2 | Melting Point | 268-278ºC |
| MSDS | ChineseUSA | Flash Point | 114.5±25.4 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | DL-Pipecolinic Acid |
|---|---|
| Synonym | More Synonyms |
Pipecolinic acid BiologicalActivity
| Description | Pipecolic acid is a metabolite of lysine. |
|---|---|
| Related Catalog | Research Areas >>InfectionNatural Products >>Acids and AldehydesResearch Areas >>Metabolic Disease |
| Target | Human Endogenous Metabolite |
| References | [1]. He M, et al. Pipecolic acid in microbes: biosynthetic routes and enzymes. J Ind Microbiol Biotechnol. 2006 Jun;33(6):401-7. |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 265.8±33.0 °C at 760 mmHg |
| Melting Point | 268-278ºC |
| Molecular Formula | C6H11NO2 |
| Molecular Weight | 129.157 |
| Flash Point | 114.5±25.4 °C |
| Exact Mass | 129.078979 |
| PSA | 49.33000 |
| LogP | 0.00 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.479 |
| InChIKey | HXEACLLIILLPRG-UHFFFAOYSA-N |
| SMILES | O=C(O)C1CCCCN1 |
| Water Solubility | soluble |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 610 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CEXPB9 Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974- Volume(issue)/page/year: 21,997,1994
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 2200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 23,1343,1968
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TK6021000 |
| HS Code | 2933399090 |
Customs
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles57
More Articles| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231) , 910-4, (2009) Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the i... | |
| Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J. Chromatogr. A. 562(1-2) , 125-38, (1991) Eighty-five clinical urine samples and nineteen urine samples previously found by other laboratories to suggest genetic metabolic defects were prepared for trimethylsilylation by treatment with urease... | |
| ECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF, and brain tissue. Adv. Exp. Med. Biol. 527 , 705-12, (2003) To study the complex inter-relationships between inflammatory and apoptotic responses and the kynurenine pathway, we have utilized electron-capture negative ion mass spectrometry to develop trace anal... |
Synonyms
| Dihydrobaikiaine |
| UNII:H254GW7PVV |
| (±)-Piperidine-2-carboxylic acid |
| DL-Pipecolinic acid |
| DL-Pipecolinicacid |
| Pipecolinic acid |
| 6-CARBOXYPIPERIDINE |
| DL-2-Piperidinecarboxylic acid |
| (±)-Pipecolinic acid |
| Pipecolic acid |
| α-Pipecolinic acid |
| .α.-Pipecolinic acid |
| a-Pipecolinic acid |
| (±)-Pipecolic acid |
| 2-Carboxypiperidine |
| piperidine-2-carboxylic acid |
| DL-Homoproline |
| DL-Pipecolic Acid |
| MFCD00064347 |
| (±)-2-Piperidinecarboxylic acid |
| EINECS 208-616-3 |
| 2-Piperidinecarboxylic acid |
| DL-PIPECOLINIC ACID:PIPERIDINE-2-CARBOXYLIC ACID |
